Filing Details

Accession Number:
0001373604-25-000030
Form Type:
13G Filing
Publication Date:
2025-02-13 19:00:00
Filed By:
BML Investment Partners, L.P.
Company:
Athira Pharma Inc. (NASDAQ:ATHA)
Filing Date:
2025-02-14
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
BML Investment Partners, L.P. 0 2,775,885 7.2%
Leonard Braden Michael 0 3,027,163 7.8%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  This amendment was filed to correct the share count and percentage ownership.


SCHEDULE 13G



Comment for Type of Reporting Person:  This amendment was filed to correct the share count and percentage ownership.


SCHEDULE 13G


 
BML Investment Partners, L.P.
 
Signature:Braden M Leonard
Name/Title:BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member
Date:02/14/2025
 
Leonard Braden Michael
 
Signature:Braden M Leonard
Name/Title:Leonard Braden Michael
Date:02/14/2025

Comments accompanying signature:  BML Investment Partners, L.P. is a Delaware limited partnership whose sole general partner is BML Capital Management, LLC. The managing member of BML Capital Management, LLC is Braden M. Leonard. As a result, Braden M. Leonard is deemed to be the indirect owner of the shares held directly by BML Investment Partners, L.P. Despite such shared beneficial ownership, the reporting persons disclaim that they constitute a statutory group within the meaning of Rule 13d-5(b)(1) of the Exchange Act.